MISSISSAUGA, ON, May 14 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ:VSGND; TSX:VAS) today announced that its President and CEO, Chris Waddick, will present a Company overview at the Rodman & Renshaw 5th Annual Global Healthcare Conference in Monte Carlo, at 12:30 p.m. local time (6:30 a.m. ET) on Monday, May 19, 2008.
A live webcast of the presentation can be accessed through Vasogen's website at http://www.vasogen.com. An archived replay will also be available following the presentation.
Vasogen is a biotechnology company engaged in the research and development of therapies designed to target the destructive inflammatory process associated with the development and progression of cardiovascular and neurodegenerative disorders.
Certain statements contained in this press release, the upcoming
presentation and webcast, or elsewhere in our public documents constitute
"forward-looking statements" within the meaning of the United States
Private Securities Litigation Reform Act of 1995 and/or "forward-looking
information" under the Securities Act (Ontario). These statements may
include, without limitation, plans to advance the development of the
Celacade(TM) System or our VP Series of drugs including VP015 and VP025,
plans to fund our current activities, statements concerning our partnering
activities, health regulatory submissions, strategy, future operations,
future financial position, future revenues and projected costs. In some
cases, you can identify forward-looking statements by terminology such as
"may", "will", "should", "expects", "plans", "anticipates", "believes",
"estimated", "predicts", "potential", "continue", "intends", "could", or
|SOURCE Vasogen Inc.|
Copyright©2008 PR Newswire.
All rights reserved